Recombinant Interleukin-2 (IL-2) Proteins
23 products
23 products
Recombinant human IL-2 plays a pivotal role in modern immunology and biomedical research. Known for its influence on immune cell regulation and activation, this powerful cytokine supports critical research in cancer immunotherapy, autoimmune conditions, and vaccine development. At Beta LifeScience, our selection of high-quality recombinant IL-2 proteins is engineered for consistency, purity, and exceptional bioactivity—helping researchers advance discovery with confidence.
From T-cell proliferation studies to immune response modulation, these recombinant proteins are an essential component in labs around the world. Whether you're exploring therapeutic mechanisms or designing new immunotherapies, our recombinant human IL-2 products offer reliable performance across a range of experimental conditions.
Interleukin-2 (IL-2) is a glycoprotein primarily secreted by activated CD4+ and CD8+ T lymphocytes. It serves as a central regulator in immune responses, initiating the expansion and differentiation of various immune cells—including T cells, B cells, and natural killer (NK) cells. IL-2 interacts with its receptor complex (IL-2R) composed of three subunits (α, β, and γ), which together trigger downstream pathways critical for immune activation.
This complex signaling cascade promotes T-cell growth, enhances cytotoxic activity, and contributes to immune homeostasis. IL-2 has been extensively studied for its therapeutic potential, especially in oncology and infectious disease research.
Recombinant human IL-2 proteins are widely used in experimental and clinical applications. These include:
By delivering consistent performance, our human recombinant IL-2 proteins help researchers uncover deeper insights into immune signaling and therapy development.
We offer a diverse range of recombinant IL-2 proteins tailored for research precision and performance. Our IL-2 products are expressed in multiple systems—E. coli, mammalian cells, yeast—to meet different study requirements. Here’s what sets our collection apart:
Whether you're working on basic research or translational science, our recombinant interleukin-2 proteins ensure consistency and reliability in every lot.
Our catalog includes both wild-type and mutant forms of recombinant human IL-2, available with or without purification tags, at varying expression levels and host systems. Whether you need IL-2 for ELISA development, cell therapy research, or in vivo models, we have a product that fits.
All IL-2 proteins are delivered lyophilized or in solution, ready for immediate use. Custom bulk orders and formulation requests are also welcome.
Cat. No. | Species | Product Description | Host | Structure | Purity | Activity | Features |
---|---|---|---|---|---|---|---|
BLC-05337P | Human | Human IL-2 Protein, Active | E.coli | P60568 (21-153aa) | > 95% | ≥1×10^7 IU/mg | SDS-PAGE, Cell Based Assay |
BLC-05319P | Human | Human IL-2 Protein, Active | Mammalian cell | P60568 21-153aa (L80F & R81D & L85V & I86V & I92F) | > 95% | ED50: 0.5 ng/mL | SDS-PAGE, Cell Based Assay |
BLC-10775P | Human | Human IL-2 Protein (GST) | E.coli | P60568 (21-153aa) | > 90% | Testing in Progress | SDS-PAGE |
BLC-05416P | Human | Human IL-2 Protein, Active, GMP | E.Coli | P60568 (21-153aa) | > 98% | > 1.0 × 107 IU/mg | SDS-PAGE, Cell Based Assay |
BLC-03457P | Human | Human IL-2 Protein (His) | E.coli | P60568 (21-153aa) | > 85% | Testing in Progress | SDS-PAGE |
BLC-03039P | Human | Human IL-2 Protein (His) | Yeast | P60568 (21-153aa) | > 90% | Testing in Progress | SDS-PAGE |
BLC-05429P | Human | Human IL-2 Protein (His), Active | Mammalian cell | P60568 (21-153aa) | > 95% | ED50: 0.5 ng/mL | SDS-PAGE, Cell Based Assay |
Human | Human IL-2 Protein, Active | Mammalian cell | P60568 (21-153aa) | > 95% | ≥ 1 x 107 IU/mg | SDS-PAGE, Cell Based Assay | |
BL-1714NP | Human | Human IL-2 Protein | E.coli | P60568 (21-153aa) | > 95% | ≥1×107 IU/mg | SDS-PAGE, Cell Based Assay, BLI |
BL-2899NP | Human | Human IL-2 Superkine Protein (Mutant, C-6His) | Mammalian cell | P60568 21-153aa (L100F, R101D, L105V, I106V, I112F) | > 95% | ED50: 151.39 pg/mL | SDS-PAGE, Cell Based Assay, BLI |
BL-2730NP | Human | Biotinylated Human IL-2 Protein (C-6His-Avi) | Mammalian cell | P60568 (21-153aa) | > 90% | ED50: 0.2 ng/mL | SDS-PAGE, Cell Based Assay, BLI, ELISA |
BL-2127NP | Human | Human IL-2 Protein (C-6His) | Mammalian cell | P60568 (21-153aa) | > 95% | ≥1×107 IU/mg | SDS-PAGE, Cell Based Assay, BLI |
BL-2887NP | Human | Human IL-2 Protein (aldesleukin) | E.coli | P60568 (22-153aa) | > 95% | ED50: 90-270 pg/mL | SDS-PAGE, Cell Based Assay, BLI |
BLC-02916P | Rhesus macaque | Rhesus Macaque IL-2 Protein (His-SUMO&Myc) | E.coli | P68291 (21-154aa) | > 90% | Testing in Progress | SDS-PAGE |
BLPSN-2803 | Canine | Canine IL-2 Protein (147 Cys/Ser) | E.coli | Q29416 (21-155aa,147Cys/Ser) | > 95% | Binds rh-IL2Ra-Fc at b/t 0.3125-20 μg/mL | SDS-PAGE, ELISA |
BLC-06764P | Llama | Lama Glama IL-2 Protein (His) | Yeast | Q865X2 (21-154aa) | > 90% | Testing in Progress | SDS-PAGE |
BLC-06596P | Llama | Lama Glama IL-2 Protein (His) | E.coli | Q865X2 (21-154aa) | > 90% | Testing in Progress | SDS-PAGE |
BLC-00201P | Golden hamster | Mesocricetus Auratus IL-2 Protein (His&StrepII) | E.coli | B3VBJ5 (21-155aa) | > 90% | Testing in Progress | SDS-PAGE |
BLC-05311P | Mouse | Mouse IL-2 Protein, Active | E.coli | P04351 (21-169aa) | > 95% | ED50: < 0.5 ng/mL. | SDS-PAGE, Cell Based Assay |
BLPSN-2805 | Mouse | Mouse IL-2 Protein | E.coli | P04351 (21-169aa) | > 92% | ED50: 6-30 ng/mL. | SDS-PAGE, Cell Based Assay, ELISA |
BLC-11012P | Rabbit | Rabbit IL-2 Protein (His) | Yeast | O77620 ( 21-153aa) | > 85% | Testing in Progress | SDS-PAGE |
BLC-04118P | Rabbit | Rabbit IL-2 Protein (His) | E.coli | O77620 ( 21-153aa) | > 90% | Testing in Progress | SDS-PAGE |
BLPSN-2806 | Rat | Rat IL-2 Protein | E.coli | P17108 (21-155aa) | > 95% | ED50: 0.5-3 ng/mL | SDS-PAGE, Cell Based Assay, ELISA |
Not all IL-2 proteins are created equal. Some projects require specialized forms of human recombinant IL-2, including engineered mutants for enhanced stability, reduced toxicity, or altered receptor binding profiles.
Beta LifeScience offers all these options under one roof to streamline your research and support next-generation immunotherapies.
We understand that research needs vary. That’s why our recombinant human interleukin 2 proteins are available in multiple formats:
No matter your system or target application, we offer a version of interleukin 2 human recombinant to suit your workflow and budget.
At Beta LifeScience, we are committed to delivering proteins that meet the highest standards in life science research:
Each IL-2 protein we produce is backed by detailed datasheets and technical documentation to support your experimental planning.
Recombinant human IL-2 is more than just a research reagent—it's a cornerstone of immunological discovery. Its ability to modulate and amplify immune responses makes it a powerful tool in both basic and applied science. At Beta LifeScience, we help researchers accelerate progress with expertly crafted IL-2 proteins designed for accuracy, purity, and biological relevance.
Explore our growing collection of recombinant human interleukin 2 proteins today and experience the Beta LifeScience difference in your lab.
Recombinant human IL-2 is widely used in immunotherapy research, especially for boosting immune cell activity against infections, tumors, and autoimmune diseases.
IL-2 is a natural cytokine made by immune cells, while recombinant IL-2 is a lab-produced version used in controlled experiments and therapeutic development.
Yes, many of our recombinant human IL-2 proteins are biologically active and tested using SDS-PAGE and cell-based assays for functionality.
Consider the host cell (e.g., E. coli, mammalian), protein tag (His, GST, etc.), and intended application. Our product descriptions list activity levels and purity to help guide your decision.
We offer GMP-grade recombinant IL-2 proteins that are suitable for translational and preclinical studies. Always verify regulatory requirements for clinical use.